Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3093

Actual shortage: 247 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2823 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2022-12-16 177672
APO-CEPHALEX 500MG TABLET Resolved 2022-12-09 2023-02-16 177678
APO-NAPROXEN 500MG TABLET Resolved 2022-12-16 2023-01-20 178742
APO-TRAZODONE D TABLETS 150MG 150MG TABLET Resolved 2022-12-16 2023-04-21 178745
APO-LEFLUNOMIDE 20MG TABLET Resolved 2022-12-16 2023-01-20 178748
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-16 2023-03-16 178751
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-16 2023-01-26 178754
APO-MIRTAZAPINE 15MG TABLET Resolved 2022-12-16 2023-01-06 178757
APO-GLICLAZIDE 80MG TABLET Resolved 2022-12-16 2022-12-23 178760
APO-ROSUVASTATIN 40MG TABLET Resolved 2022-12-16 2023-01-06 178763
APO-ABIRATERONE FILM COATED TABLETS 250MG TABLET Resolved 2022-12-16 2023-01-10 178769
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-09 178772
APO-SITAGLIPTIN/METFORMIN XR 1000MG 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-16 2023-01-20 178775
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2022-12-16 2023-02-02 178778
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2022-12-16 2023-02-02 178781
APO-ARIPIPRAZOLE 30MG TABLET Resolved 2022-12-16 2023-03-30 178784
APO-ARIPIPRAZOLE 30MG TABLET Resolved 2022-12-16 2023-03-30 178787
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2022-12-16 2023-03-02 178790
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2022-12-16 2023-03-02 178793
APO-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-23 2023-03-23 179437

Showing 2401 to 2420 of 3093

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40823
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40826
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Discontinued 2018-02-23 2018-05-07 40829
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Discontinued 2018-02-23 2018-05-07 40832
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-02-23 2018-02-28 40835
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-02-23 2018-05-07 40838
ANTI-NAUSEANT 50MG TABLET Discontinued 2018-02-23 2018-09-12 40841
ANTI-NAUSEANT 50MG TABLET Discontinued 2018-02-23 2018-10-25 40844
APO-SALVENT TABLETS - 4MG 4MG TABLET Discontinued 2018-02-23 2018-07-17 40847
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40947
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-26 2018-02-26 40957
APO-ZOLMITRIPTAN 2.5MG TABLET Discontinued 2018-02-26 2018-02-26 40960
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047
APO-CEFPROZIL 500MG TABLET Discontinued 2018-04-04 2018-10-05 44945
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998

Showing 61 to 80 of 356